MENU
SPRY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ARS Pharmaceuticals (SPRY) Earnings Date & Reports

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis... Show more

A.I. Advisor
published Earnings

SPRY is expected to report earnings to fall 13.78% to -39 cents per share on November 06

ARS Pharmaceuticals SPRY Stock Earnings Reports
Q3'25
Est.
$-0.40
Q2'25
Est.
$-0.46
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.61
Q3'24
Missed
by $0.06
The last earnings report on August 13 showed earnings per share of -46 cents, meeting the estimate of -46 cents. With 2.89M shares outstanding, the current market capitalization sits at 1.44B.
View a ticker or compare two or three
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SPRY showed earnings on August 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11682 El Camino Real
Phone
+1 858 771-9307
Employees
26
Web
https://www.ars-pharma.com